Prognostic Value of Ki-67 for Recurrence and Progression of Superficial Bladder Cancer-Reference-Cited by-同舟云学术

Prognostic Value of Ki-67 for Recurrence and Progression of Superficial Bladder Cancer

Published:1997-08 Issue:2 Volume:158 Page:385-388
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Asakura Tomoyuki¹,Takano Yasuo¹,Iki Masayuki¹,Suwa Yutaka¹,Noguchi Sumio¹,Kubota Yoshinobu¹,Masuda Mitsunobu¹

Affiliation:

1. Department of Urology, Yokohama City University School of Medicine, Yokohama-shi and Department of Pathology, Kitasato University School of Medicine, Sagamihara-shi, Kanagawa-ken, and Department of Environmental Health, Fukui Medical School, Yoshida-gun, Fukui-ken, Japan.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference24 articles.

1. Superficial bladder cancer: progression and recurrence;Heney;J. Urol.,1983

2. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer.;Kiemeney;J. Urol.,1993

3. Factors influencing the recurrence rate of bladder cancer.;Loening;J. Urol.,1980

4. Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group;Dalesio;J. Urol.,1983

5. Factors affecting recurrence rates in superficial bladder cancer.;Koch;J. Nat. Cancer Inst.,1986

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nested Variant Urothelial Carcinoma of the Bladder;Urology;2020-10

2. Progressive tissue biomarker profiling in non-muscle-invasive bladder cancer;Expert Review of Anticancer Therapy;2018-05-09

3. Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis;Oncotarget;2017-10-13

4. Immunohistochemical Analysis of Urothelial Carcinoma Tissues for Proliferation and Differentiation Markers;Urothelial Carcinoma;2017-09-10

5. High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma;Medicine;2016-04